Clinical Trial Update: Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating endostatin in combination with a TC regimen for liver metastases arising from non-small cell lung cancer and nasopharyngeal ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastasis
• Nasopharyngeal Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Endostatin (endostatin)
• TC regimen

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non Small Cell Lung Cancer, Nasopharyngeal Cancer | Phase 2 | Status: UNKNOWN